BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 17699853)

  • 21. Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells.
    Hsieh SH; Ying NW; Wu MH; Chiang WF; Hsu CL; Wong TY; Jin YT; Hong TM; Chen YL
    Oncogene; 2008 Jun; 27(26):3746-53. PubMed ID: 18223683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small-cell lung cancer.
    Moncho-Amor V; Ibañez de Cáceres I; Bandres E; Martínez-Poveda B; Orgaz JL; Sánchez-Pérez I; Zazo S; Rovira A; Albanell J; Jiménez B; Rojo F; Belda-Iniesta C; García-Foncillas J; Perona R
    Oncogene; 2011 Feb; 30(6):668-78. PubMed ID: 20890299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling.
    Shintani Y; Takashima S; Asano Y; Kato H; Liao Y; Yamazaki S; Tsukamoto O; Seguchi O; Yamamoto H; Fukushima T; Sugahara K; Kitakaze M; Hori M
    EMBO J; 2006 Jul; 25(13):3045-55. PubMed ID: 16763549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of the neuropilin 1 (NRP1) gene correlated with poor prognosis in human glioma.
    Osada H; Tokunaga T; Nishi M; Hatanaka H; Abe Y; Tsugu A; Kijima H; Yamazaki H; Ueyama Y; Nakamura M
    Anticancer Res; 2004; 24(2B):547-52. PubMed ID: 15160992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
    Guo B; Zhang Y; Luo G; Li L; Zhang J
    Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway.
    Suzuki C; Daigo Y; Ishikawa N; Kato T; Hayama S; Ito T; Tsuchiya E; Nakamura Y
    Cancer Res; 2005 Dec; 65(24):11314-25. PubMed ID: 16357138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
    Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
    Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropilin 1 expression correlates with the Radio-resistance of human non-small-cell lung cancer cells.
    Dong JC; Gao H; Zuo SY; Zhang HQ; Zhao G; Sun SL; Han HL; Jin LL; Shao LH; Wei W; Jin SZ
    J Cell Mol Med; 2015 Sep; 19(9):2286-95. PubMed ID: 26147006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor immunostaining correlates with postoperative relapse and survival in non-small cell lung cancer.
    Yilmaz A; Ernam D; Unsal E; Demirag F; Atikcan S; Taştepe I
    Arch Med Res; 2007 Oct; 38(7):764-8. PubMed ID: 17845896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells.
    Dai J; Peng L; Fan K; Wang H; Wei R; Ji G; Cai J; Lu B; Li B; Zhang D; Kang Y; Tan M; Qian W; Guo Y
    Oncogene; 2009 Sep; 28(38):3412-22. PubMed ID: 19597469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer.
    Zhao M; Gao FH; Wang JY; Liu F; Yuan HH; Zhang WY; Jiang B
    Lung Cancer; 2011 Sep; 73(3):366-74. PubMed ID: 21333372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiangiogenic therapy in nonsmall cell lung cancer.
    Gutierrez M; Giaccone G
    Curr Opin Oncol; 2008 Mar; 20(2):176-82. PubMed ID: 18300767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
    Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
    Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and Vascular Endothelial Growth Factor (VEGF).
    Lin SS; Lai KC; Hsu SC; Yang JS; Kuo CL; Lin JP; Ma YS; Wu CC; Chung JG
    Cancer Lett; 2009 Nov; 285(2):127-33. PubMed ID: 19477063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet-derived growth factor-AA is an essential and autocrine regulator of vascular endothelial growth factor expression in non-small cell lung carcinomas.
    Shikada Y; Yonemitsu Y; Koga T; Onimaru M; Nakano T; Okano S; Sata S; Nakagawa K; Yoshino I; Maehara Y; Sueishi K
    Cancer Res; 2005 Aug; 65(16):7241-8. PubMed ID: 16103075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells.
    Potiron VA; Sharma G; Nasarre P; Clarhaut JA; Augustin HG; Gemmill RM; Roche J; Drabkin HA
    Cancer Res; 2007 Sep; 67(18):8708-15. PubMed ID: 17875711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbonyl reductase expression and its clinical significance in non-small-cell lung cancer.
    Takenaka K; Ogawa E; Oyanagi H; Wada H; Tanaka F
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1972-5. PubMed ID: 16103446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.
    Huang Y; Hua K; Zhou X; Jin H; Chen X; Lu X; Yu Y; Zha X; Feng Y
    Cell Res; 2008 Jul; 18(7):780-91. PubMed ID: 18574502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1.
    Hayashi H; Nakagami H; Takami Y; Koriyama H; Mori M; Tamai K; Sun J; Nagao K; Morishita R; Kaneda Y
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):909-14. PubMed ID: 19325137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.